1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Rigosertib: new trials by email Literature Review of Rigosertib trials Research Report on Rigosertib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts ON 01910.Na - Myelodysplastic Syndromes, MDS | Phase 3 | Completed | Traws Pharma, Inc. | 299 | 2010-11-01 | 2020-06-30 |
Anemia, Refractory, with Excess of Blasts (1) · Leukemia, Myelomonocytic, Chronic (1) · Myelodysplastic Syndromes (1)
Belgium (1) · France (1) · Germany (1) · Italy (1) · Spain (1) · United States (1)